Drug Profile
Cevipabulin
Alternative Names: Cevipabulin fumarate; TAP-237; TTI-237Latest Information Update: 07 Aug 2009
Price :
$50
*
At a glance
- Originator Wyeth
- Class Antineoplastics; Pyrimidines; Small molecules
- Mechanism of Action Tubulin polymerisation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Solid tumours
Most Recent Events
- 21 Sep 2005 Phase-I clinical trials in Solid tumours in USA (IV)